47 results
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
, pension, retirement, deferred compensation, profit-sharing, health, welfare, fringe benefit, vacation or other benefit or compensation plan, program … or worker health and safety (solely to the extent related to human exposure to Hazardous Materials).
“ERISA” means the Employee Retirement Income
8-K/A
EX-99.1
CHRS
Coherus Biosciences Inc
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
are charged to expense as incurred. Upon retirement or sale, the cost and related accumulated depreciation and amortization of assets disposed of are removed
424B3
o2ayj3jmznn644u
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
iv36fv58pgp
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
osqe3 bse
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
7bhd56
16 Jun 23
Business combination disclosure
8:08am
425
8o27x8iab5pn5t vo
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
j83omoniau0
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
wk1mqs1gw2t8a1gbnv
18 May 23
Other Events
5:02pm
424B5
xg0 m15k1d6wtlcvj7
17 May 23
Prospectus supplement for primary offering
4:02pm
424B5
oc6sf839bk
16 May 23
Prospectus supplement for primary offering
6:07am